Page 64 - Read Online
P. 64

Chan et al. Hepatoma Res 2018;4:5  I  http://dx.doi.org/10.20517/2394-5079.2017.49                                                 Page 13 of 17


                   underwent partial hepatectomy in a single center. World J Surg 2010;34:2434-41.
               24.  Yamashita Y, Taketomi A, Shirabe K, Aishima S, Tsuijita E, Morita K, Kayashima H, Maehara Y. Outcomes of hepatic resection for huge
                   hepatocellular carcinoma (>/= 10 cm in diameter). J Surg Oncol 2011;104:292-8.
               25.  Ruzzenente A, Guglielmi A, Sandri M, Campagnaro T, Valdegamberi A, Conci S, Bagante F, Turcato G, D’Onofrio M, Iacono C. Surgical
                   resection versus local ablation for HCC on cirrhosis: results from a propensity case-matched study. J Gastrointest Surg 2012;16:301-11;
                   discussion 11.
               26.  Luo J, Peng ZW, Guo RP, Zhang YQ, Li JQ, Chen MS, Shi M. Hepatic resection versus transarterial lipiodol chemoembolization as
                   the initial treatment for large, multiple, and resectable hepatocellular carcinomas: a prospective nonrandomized analysis. Radiology
                   2011;259:286-95.
               27.  Zhou L, Rui JA, Wang SB, Chen SG, Qu Q. Prognostic factors of solitary large hepatocellular carcinoma: the importance of differentiation
                   grade. Eur J Surg Oncol 2011;37:521-5.
               28.  Chang WT, Kao WY, Chau GY, Su CW, Lei HJ, Wu JC, Hsia CY, Lui WY, King KL, Lee SD. Hepatic resection can provide long-term
                   survival of patients with non-early-stage hepatocellular carcinoma: extending the indication for resection? Surgery 2012;152:809-20.
               29.  Galun DA, Bulajic P, Zuvela M, Basaric D, Ille T, Milicevic MN. Is there any benefit from expanding the criteria for the resection of
                   hepatocellular carcinoma in cirrhotic liver? Experience from a developing country. World J Surg 2012;36:1657-65.
               30.  Huang JF, Wu SM, Wu TH, Lee CF, Wu TJ, Yu MC, Chan KM, Lee WC. Liver resection for complicated hepatocellular carcinoma:
                   challenges but opportunity for long-term survivals. J Surg Oncol 2012;106:959-65.
               31.  Shrager B, Jibara GA, Tabrizian P, Schwartz ME, Labow DM, Hiotis S. Resection of large hepatocellular carcinoma (>/= 10 cm): a unique
                   western perspective. J Surg Oncol 2013;107:111-7.
               32.  Allemann P, Demartines N, Bouzourene H, Tempia A, Halkic N. Long-term outcome after liver resection for hepatocellular carcinoma
                   larger than 10 cm. World J Surg 2013;37:452-8.
               33.  Ariizumi S, Kotera Y, Takahashi Y, Katagiri S, Yamamoto M. Impact of hepatectomy for huge solitary hepatocellular carcinoma. J Surg
                   Oncol 2013;107:408-13.
               34.  Yin L, Li H, Li AJ, Lau WY, Pan ZY, Lai EC, Wu MC, Zhou WP. Partial hepatectomy vs. transcatheter arterial chemoembolization for
                   resectable multiple hepatocellular carcinoma beyond Milan Criteria: a RCT. J Hepatol 2014;61:82-8.
               35.  Chan YC, Kabiling CS, Pillai VG, Aguilar G, Wang CC, Chen CL. Survival outcome between hepatic resection and transarterial
                   embolization for hepatocellular carcinoma more than 10 cm: a propensity score model. World J Surg 2015;39:1510-8.
               36.  Chang YJ, Chung KP, Chang YJ, Chen LJ. Long-term survival of patients undergoing liver resection for very large hepatocellular
                   carcinomas. Br J Surg 2016;103:1513-20.
               37.  Liu PH, Su CW, Hsu CY, Hsia CY, Lee YH, Huang YH, Lee RC, Lin HC, Huo TI. Solitary large hepatocellular carcinoma: staging and
                   treatment strategy. PLoS One 2016;11:e0155588.
               38.  Zhao HC, Wu RL, Liu FB, Zhao YJ, Wang GB, Zhang ZG, Huang F, Xie K, Geng XP. A retrospective analysis of long term outcomes in
                   patients undergoing hepatic resection for large (>5 cm) hepatocellular carcinoma. HPB (Oxford) 2016;18:943-9.
               39.  Jin YJ, Lee JW. Therapeutic priorities for solitary large hepatocellular carcinoma in a hepatitis B virus endemic area; an analysis of a
                   nationwide cancer registry database. J Surg Oncol 2017;115:407-16.
               40.  Kumada K, Ozawa K, Okamoto R, Takayasu T, Yamaguchi M, Yamamoto Y, Higashiyama H, Morikawa S, Sasaki H, Shimahara Y. Hepatic
                   resection for advanced hepatocellular carcinoma with removal of portal vein tumor thrombi. Surgery 1990;108:821-7.
               41.  Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999;19:329-38.
               42.  Ban D, Shimada K, Yamamoto Y, Nara S, Esaki M, Sakamoto Y, Kosuge T. Efficacy of a hepatectomy and a tumor thrombectomy for
                   hepatocellular carcinoma with tumor thrombus extending to the main portal vein. J Gastrointest Surg 2009;13:1921-8.
               43.  Peng ZW, Guo RP, Zhang YJ, Lin XJ, Chen MS, Lau WY. Hepatic resection versus transcatheter arterial chemoembolization for the
                   treatment of hepatocellular carcinoma with portal vein tumor thrombus. Cancer 2012;118:4725-36.
               44.  Kojima H, Hatano E, Taura K, Seo S, Yasuchika K, Uemoto S. Hepatic resection for hepatocellular carcinoma with tumor thrombus in the
                   major portal vein. Dig Surg 2015;32:413-20.
               45.  Kokudo T, Hasegawa K, Matsuyama Y, Takayama T, Izumi N, Kadoya M, Kudo M, Ku Y, Sakamoto M, Nakashima O, Kaneko S, Kokudo
                   N; Liver Cancer Study Group of Japan. Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion.
                   J Hepatol 2016;65:938-43.
               46.  Roayaie S, Jibara G, Taouli B, Schwartz M. Resection of hepatocellular carcinoma with macroscopic vascular invasion. Ann Surg Oncol
                   2013;20:3754-60.
               47.  Lee JM, Jang BK, Lee YJ, Choi WY, Choi SM, Chung WJ, Hwang JS, Kang KJ, Kim YH, Chauhan AK, Park SY, Tak WY, Kweon YO,
                   Kim BS, Lee CH. Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular
                   carcinoma with portal vein tumor thrombosis. Clin Mol Hepatol 2016;22:160-7.
               48.  Liu PH, Lee YH, Hsia CY, Hsu CY, Huang YH, Chiou YY, Lin HC, Huo TI. Surgical resection versus transarterial chemoembolization for
                   hepatocellular carcinoma with portal vein tumor thrombosis: a propensity score analysis. Ann Surg Oncol 2014;21:1825-33.
               49.  Zheng N, Wei X, Zhang D, Chai W, Che M, Wang J, Du B. Hepatic resection or transarterial chemoembolization for hepatocellular
                   carcinoma with portal vein tumor thrombus. Medicine (Baltimore) 2016;95:e3959.
               50.  Chen JS, Wang Q, Chen XL, Huang XH, Liang LJ, Lei J, Huang JQ, Li DM, Cheng ZX. Clinicopathologic characteristics and surgical
                   outcomes of hepatocellular carcinoma with portal vein tumor thrombosis. J Surg Res 2012;175:243-50.
               51.  Li N, Feng S, Xue J, Wei XB, Shi J, Guo WX, Lau WY, Wu MC, Cheng SQ, Meng Y. Hepatocellular carcinoma with main portal vein
                   tumor thrombus: a comparative study comparing hepatectomy with or without neoadjuvant radiotherapy. HPB (Oxford) 2016;18:549-56.
               52.  Matono R, Yoshiya S, Motomura T, Toshima T, Kayashima H, Masuda T, Yoshizumi T, Taketomi A, Shirabe K, Maehara Y. Factors linked
                   to longterm survival of patients with hepatocellular carcinoma accompanied by tumour thrombus in the major portal vein after surgical
                   resection. HPB (Oxford) 2012;14:247-53.
   59   60   61   62   63   64   65   66   67   68   69